Clinical trial Recruiting at 7 sites Interventional Ages 18 and up

Time‑variant pulse spinal cord stimulation for chronic low back and leg pain

Official title: Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control (MOSAIC Study)

Run by Boston Scientific Corporation · NCT07190807 · Data updated 2026-11-12

This trial will test whether time‑variant pulse spinal cord stimulation using the Boston Scientific WaveWriter Alpha system can reduce chronic low back or leg pain in adults who have not found relief from other treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorBoston Scientific Corporation
Industry-sponsored
Locations7 sites (Greenwood, Colorado and 6 other locations)
StatusRecruiting
StartedNovember 7, 2025
Main results expectedNovember 2027
Study endsMay 2029
Registry record updatedOctober 13, 2026
Trial IDNCT07190807 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with chronic trunk or limb pain for at least six months, diagnosed with PSPS Type I or II (including failed back surgery), who can read English and provide informed consent are the intended candidates.

Probably not a fit

Patients with other pain diagnoses likely to confound outcomes (for example vascular or neurogenic claudication, acute herniated disc, malignancy, untreated major depression), significant cognitive impairment, or active injury claims are unlikely to receive benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses commercially approved Boston Scientific WaveWriter Alpha spinal cord stimulation systems, delivered per local instructions for use, to apply a time‑variant pulse (TVP) waveform in patients with chronic trunk and/or limb pain. Eligible adults have persistent spinal pain syndrome (PSPS) Type I or II or non‑surgical refractory back pain and symptoms for at least six months. The study will collect real‑world clinical outcomes and patient‑reported measures at participating sites to characterize pain response to TVP‑SCS. Enrollment and follow‑up involve in‑clinic visits at designated U.S. centers and completion of English questionnaires.

Why it matters

Potential benefit: If successful, this approach could provide better or more durable pain relief and improved daily function for people with chronic low back and/or leg pain.

How similar studies have gone: Spinal cord stimulation is an established therapy for chronic low back and leg pain and prior studies of varied SCS waveforms have shown benefit, though time‑variant pulse (TVP) approaches are relatively newer and less extensively studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Key Inclusion Criteria:

* Persistent spinal pain syndrome (PSPS) Type I (or non-surgical refractory back pain), or PSPS Type II (Failed Back Surgery Syndrome, FBSS) diagnosis.
* Diagnosed with chronic pain of the trunk and/or limbs for at least 6 months.
* 18 years of age or older when written informed consent is obtained
* Able to independently read and complete all questionnaires and assessments provided in English.
* Signed a valid, IRB or EC approved informed consent form (ICF) provided in English.

Key Exclusion Criteria:

* Any pain-related diagnosis, medical or psychological condition that, in the Investigator's judgment might confound reporting of study outcomes (e.g., vascular or neurogenic claudication, osteoarthritis, plantar fasciitis, pelvic pain, anginal pain, chronic migraine, acute herniated disc, malignancy, untreated major depression, injury claim).
* Significant cognitive impairment at Screening and Baseline visit that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
* A female who is pregnant, lactating, or is of childbearing potential and planning to get pregnant during the study or not using adequate contraception.
* Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study.

Where it's running

  • Denver Back Pain Specialists
    Greenwood, Colorado, United States
    Recruiting
  • Orlando Health Neuroscience Institute
    Clermont, Florida, United States
    Recruiting
  • Ochsner Clinic Foundation
    New Orleans, Louisiana, United States
    Recruiting
  • Montefiore Medical Center
    The Bronx, New York, United States
    Recruiting
  • Fox Chase Pain Management
    Trevose, Pennsylvania, United States
    Recruiting
  • PCPMG Clinical Research Unit, LLC
    Greenville, South Carolina, United States
    Recruiting
Show 1 more location
  • Institute of Precision Pain Medicine
    Corpus Christi, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.